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The UK Medical Research Council (MRC) is 100 years
old this year. Its ‘Centenary Timeline’ contains the
following brief reference to the Council’s role in the
development of clinical trials:
1940-1949: Randomised controlled trial design
pioneered
MRC scientists developed what is today the gold stan-
dard for clinical trial design while testing streptomycin
to treat pulmonary tuberculosis.
Although the MRC failed to make any substantive
contribution to the development of trial methods before
the 1940s, it made exceptionally important contributions
between 1944 and 1960. Surprisingly, the Council has
been curiously silent about the enduring value of its role
in developing clinical trial methods, and about the
important methodological legacy left by the director of
its Statistical Research Unit - Austin Bradford Hill.
Stephen Lock, a former editor of the British Medical
Journal, has suggested that ‘the randomised controlled
trial is a British invention’ and that Bradford Hill should
have been awarded a Nobel prize for his key role in
helping to put medicine on a rational scientific footing.
Some of us think that it is high time that the Council
made more of its historic achievement.
For details see: Chalmers I (2013). The MRC and multi-
centre clinical trials: from a damning report to international
recognition. JLL Bulletin: Commentaries on the history of
treatment evaluation (http://www.jameslindlibrary.org).
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